A Phase II/III clinical trial to assess safety and immunogenicity of the Pandemic influenza vaccine (Human, live attenuated) A (H1N1) 2009 of SIIL In Adults, Elderly and Pediatric Populations.
Phase of Trial: Phase II/III
Latest Information Update: 30 Aug 2016
At a glance
- Drugs Influenza A virus vaccine-H1N1 (Primary)
- Indications Influenza A virus H1N1 subtype
- Focus Adverse reactions
- Sponsors Serum Institute of India
- 11 Jul 2010 Status changed from active, no longer recruiting to completed as reported by Clinical Trials Registry - India.
- 20 Mar 2010 Status changed from recruiting to active, no longer recruiting as reported by Clinical Trials Registry - India.
- 10 Mar 2010 Actual initiation date (8 Mar 2010) added as reported by Clinical Trials Registry - India.